Stocks · News reference
Cosmos Health Reaffirms FY 2029 Guidance, Expects $200.60M Revenue, $71.20M Gross Profit, $31M Net Income, $44.20M Adjusted EBITDA
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — Cosmos Health Inc. (COSM)
Filed: 2026-08-20 AccNo: 0001477932-26-005195 Size: 344 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Cosmos Health shares are trading higher after the company announced an exclusive distribution agreement with Innova Healthcare for 126K units of its proprietary Sky Premium Life range of food supplements.